Last $12.32 USD
Change Today -0.11 / -0.88%
Volume 1.0M
As of 2:12 PM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - exact sciences corp (EXAS)

Name (Connections)Board RelationshipsTitleKey Developments
Sally Crawford 96 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Audit Committee 
Lionel Sterling 16 RelationshipsIndependent Director and Chairman of Audit Committee 
Thomas Carey 6 RelationshipsIndependent Director, Member of Compensation Committee and Member of Audit Committee 

Compensation Committee* - exact sciences corp (EXAS)

Name (Connections)Board RelationshipsTitle
Thomas Carey 6 RelationshipsIndependent Director, Member of Compensation Committee and Member of Audit Committee
Sally Crawford 96 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Audit Committee
Katherine Napier 29 RelationshipsIndependent Director, Chairman of Innovation & Technology Committee and Member of Compensation Committee
EXAS Compensation vs. Industry
445.8K
351.1K
Chief Executive Officer
325.0K
249.9K
Chief Operating Officer
Share price activity for EXACT SCIENCES CORP (EXAS)
52 Week Price Performance
EXAS
Industry Average

Nominating Committee* - exact sciences corp (EXAS)

Name (Connections)Board RelationshipsTitleKey Developments
David Thompson Ph.D. 6 RelationshipsLead Independent Director and Chairman of Corporate Governance & Nominating CommitteeExact Sciences Corporation Announces Executive Changes
03/21/14
Daniel Levangie B.S. 56 RelationshipsIndependent Director, Member of Corporate Governance & Nominating Committee and Member of Innovation & Technology CommitteeExact Sciences Corporation Announces Executive Changes
08/30/13

Corporate Governance Committee* - exact sciences corp (EXAS)

Name (Connections)Board RelationshipsTitle
Daniel Levangie B.S. 56 RelationshipsIndependent Director, Member of Compensation Committee and Member of Audit Committee
David Thompson Ph.D. 6 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Audit Committee
EXAS and Competitor
Insiders vs. External
Board
14%
86%
Exact Sciences Corporation
33%
67%
Immunomedics Inc.
6%
94%
Navidea Biopharmaceuticals, Inc
14%
86%
Keryx Biopharmaceuticals Inc.
0%
100%
Delcath Systems, Inc.
8%
92%
Celldex Therapeutics, Inc.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXAS:US $12.34 USD -0.09

EXAS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Celldex Therapeutics Inc $14.52 USD +0.79
Delcath Systems Inc $3.83 USD +0.04
Immunomedics Inc $3.90 USD +0.07
Keryx Biopharmaceuticals Inc $13.90 USD -0.01
Navidea Biopharmaceuticals Inc $1.64 USD 0.00
View Industry Companies
 

Industry Analysis

EXAS

Industry Average

Valuation EXAS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 212.2x
Price/Book 6.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 211.2x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXACT SCIENCES CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.